{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T02:35:01Z","timestamp":1782786901788,"version":"3.54.5"},"reference-count":126,"publisher":"Wiley","issue":"S1","license":[{"start":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T00:00:00Z","timestamp":1604361600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100003572","name":"american academy of otolaryngic allergy foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003572","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aao-hnsfjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Otolaryngol.--head neck surg."],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:p>Biologic agents, monoclonal antibodies that target highly\u2010specific molecular pathways of inflammation, are becoming integrated into care pathways for multiple disorders that are relevant in otolaryngology and allergy. These conditions share common inflammatory mechanisms of so\u2010called Type 2\u00a0inflammation with dysregulation of immunoglobulin E production and eosinophil and mast cell degranulation leading to tissue damage. Biologic agents are now available for the treatment of chronic rhinosinusitis with nasal polyps (CRSwNP), asthma, eosinophilic granulomatosis with polyangiitis (EGPA), atopic dermatitis (AD), and chronic spontaneous urticaria (CSU). This paper summarizes the diagnosis and management of these conditions and critically reviews the clinical trial data that has led to regulatory approval of biologic agents for these conditions.<\/jats:p>","DOI":"10.1177\/0194599820965233","type":"journal-article","created":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T04:00:38Z","timestamp":1604376038000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Targeted Molecular Therapies in Allergy and Rhinology"],"prefix":"10.1002","volume":"164","author":[{"given":"Cecelia C.","family":"Damask","sequence":"first","affiliation":[{"name":"University of Central Florida Lake Mary Florida USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew W.","family":"Ryan","sequence":"additional","affiliation":[{"name":"UT Southwestern Medical Center Dallas Texas USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas B.","family":"Casale","sequence":"additional","affiliation":[{"name":"University of South Florida Tampa Florida USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Castro","sequence":"additional","affiliation":[{"name":"University of Kansas Medical Center Kansas City Kansas USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine B.","family":"Franzese","sequence":"additional","affiliation":[{"name":"University of Missouri Medical Center Columbia Missouri USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella E.","family":"Lee","sequence":"additional","affiliation":[{"name":"University of Pittsburgh Pittsburgh Pennsylvania USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua M.","family":"Levy","sequence":"additional","affiliation":[{"name":"Emory Medicine Atlanta Georgia USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra Y.","family":"Lin","sequence":"additional","affiliation":[{"name":"Johns Hopkins Medicine Baltimore Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"Lio","sequence":"additional","affiliation":[{"name":"Northwestern Medicine Chicago Illinois USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anju T.","family":"Peters","sequence":"additional","affiliation":[{"name":"Northwestern Medicine Chicago Illinois USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Platt","sequence":"additional","affiliation":[{"name":"Boston Medical Center Boston Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew A.","family":"White","sequence":"additional","affiliation":[{"name":"Scripps Clinic La Jolla California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,11,3]]},"reference":[{"key":"e_1_2_16_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1081-1206(10)61928-X"},{"key":"e_1_2_16_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/366421a0"},{"key":"e_1_2_16_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0952-7915(97)80182-3"},{"key":"e_1_2_16_5_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M117.776476"},{"key":"e_1_2_16_6_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.151.5.2623"},{"key":"e_1_2_16_7_1","doi-asserted-by":"publisher","DOI":"10.1021\/bi9928391"},{"issue":"3","key":"e_1_2_16_8_1","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.4049\/jimmunol.158.3.1438","article-title":"Downregulation of Fc(epsilon)RI on human basophils during in vivo treatment of atopic patients with anti\u2010IgE antibody","volume":"158","author":"MacGlashan DW","year":"1997","journal-title":"J Immunol"},{"key":"e_1_2_16_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2003.11.044"},{"key":"e_1_2_16_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2004.06.032"},{"key":"e_1_2_16_11_1","unstructured":"StokesJ CasaleT.Anti\u2010IgE therapy. Accessed April 16 2019.https:\/\/www.uptodate.com\/contents\/anti\u2010igetherapy"},{"key":"e_1_2_16_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2018.02.029"},{"key":"e_1_2_16_13_1","article-title":"Anti\u2010IL5 therapies for asthma","volume":"9","author":"Farne HA","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_16_14_1","first-page":"125","article-title":"The past, present, and future of monoclonal antibodies to IL\u20105 and eosinophilic asthma: a review","volume":"8","author":"Patterson MF","year":"2015","journal-title":"J Asthma Allergy"},{"key":"e_1_2_16_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2016.07.015"},{"key":"e_1_2_16_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(15)00367-7"},{"key":"e_1_2_16_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.iac.2017.01.007"},{"key":"e_1_2_16_18_1","doi-asserted-by":"publisher","DOI":"10.1177\/1753465816667659"},{"key":"e_1_2_16_19_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19103086"},{"key":"e_1_2_16_20_1","doi-asserted-by":"publisher","DOI":"10.1159\/000447692"},{"key":"e_1_2_16_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2015.12.025"},{"key":"e_1_2_16_22_1","doi-asserted-by":"publisher","DOI":"10.1186\/1465-9921-12-59"},{"key":"e_1_2_16_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2018.08.022"},{"key":"e_1_2_16_24_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1304048"},{"issue":"2","key":"e_1_2_16_25_1","first-page":"S1","article-title":"Clinical practice guideline (update): adult sinusitis","volume":"152","author":"Rosenfeld RM","year":"2015","journal-title":"Otolaryngol Head Neck Surg"},{"key":"e_1_2_16_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2015.12.1324"},{"issue":"3","key":"e_1_2_16_27_1","first-page":"1010","article-title":"Clinical characteristics of patients with chronic rhinosinusitis without nasal polyps in an academic setting","volume":"7","author":"Benjamin MR","year":"2019","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"e_1_2_16_28_1","article-title":"International consensus statement on allergy and rhinology: rhinosinusitis","volume":"6","author":"Orlandi RR","year":"2016","journal-title":"Int Forum Allergy Rhinol"},{"key":"e_1_2_16_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2010.02.020"},{"key":"e_1_2_16_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2006.03.012"},{"key":"e_1_2_16_31_1","doi-asserted-by":"publisher","DOI":"10.1080\/00016480500504226"},{"key":"e_1_2_16_32_1","first-page":"1","article-title":"European position paper on rhinosinusitis and nasal polyps 2012","volume":"23","author":"Fokkens WJ","year":"2012","journal-title":"Rhinol Suppl"},{"key":"e_1_2_16_33_1","doi-asserted-by":"publisher","DOI":"10.1177\/1945892418810281"},{"issue":"4","key":"e_1_2_16_34_1","first-page":"183","article-title":"Staging in rhinosinusitus","volume":"31","author":"Lund VJ","year":"1993","journal-title":"Rhinology"},{"key":"e_1_2_16_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/all.12415"},{"key":"e_1_2_16_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2012.08.023"},{"key":"e_1_2_16_37_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.19330"},{"key":"e_1_2_16_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2018.12.948"},{"key":"e_1_2_16_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2018.12.980"},{"key":"e_1_2_16_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140\u20106736(19)31881\u20101"},{"key":"e_1_2_16_41_1","unstructured":"ClinicalTrials.gov.Dupilumab for aspirin\u2010exacerbated respiratory disease. Accessed May 29 2019.https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03595488"},{"key":"e_1_2_16_42_1","doi-asserted-by":"publisher","DOI":"10.2500\/ajr.2007.21.3060"},{"key":"e_1_2_16_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2012.07.047"},{"key":"e_1_2_16_44_1","doi-asserted-by":"publisher","DOI":"10.4193\/Rhin09.144"},{"key":"e_1_2_16_45_1","unstructured":"ClinicalTrials.gov.A clinical trial of omalizumab in participants with chronic rhinosinusitis with nasal polyps (POLYP 1). Accessed May 29 2019.https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03280550?term=NCT03280550&rank=1"},{"key":"e_1_2_16_46_1","unstructured":"ClinicalTrials.gov.A clinical trial of omalizumab in participants with chronic rhinosinusitus with nasal polyps (POLYP 2). Accessed May 29 2019.https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03280537?term=NCT03280537&rank=1"},{"key":"e_1_2_16_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2020.05.032"},{"key":"e_1_2_16_48_1","unstructured":"Genentech.Xolair (omalizumab) significantly reduced nasal polyps and congestion symptoms in adults with chronic rhinosinusitis with nasal polyps in two phase III studies. Accessed October 24 2019.https:\/\/www.gene.com\/media\/press\u2010releases\/14792\/2019\u201006\u201002\/xolair\u2010omalizumab\u2010significantly\u2010reduced\u2010"},{"key":"e_1_2_16_49_1","unstructured":"Clinicaltrials.gov.An extension study of omalizumab in participants with chronic rhinosinusitis with nasal polyps. Accessed May 29 2019.https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03478930"},{"key":"e_1_2_16_50_1","doi-asserted-by":"publisher","DOI":"10.4193\/Rhin17.139"},{"key":"e_1_2_16_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2011.07.056"},{"key":"e_1_2_16_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2017.05.044"},{"key":"e_1_2_16_53_1","unstructured":"ClinicalTrials.gov.Effect of mepolizumab in severe bilateral nasal polyps. Accessed May 29 2019.https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03085797?term=mepolizumab+and+nasal+polyps&rank=1"},{"key":"e_1_2_16_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2006.05.031"},{"key":"e_1_2_16_55_1","unstructured":"ClinicalTrials.gov.Study of benralizumab (KHK4563) in patients with eosinophilic chronic rhinosinusitis. Accessed May 29 2019.https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02772419"},{"key":"e_1_2_16_56_1","unstructured":"ClinicalTrials.gov.Benralizumab effect on severe chronic rhinosinusitis with eosinophilic polyposis. Accessed May 29 2019.https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03450083?term=NCT03450083&rank=1"},{"key":"e_1_2_16_57_1","unstructured":"ClinicalTrials.gov.Efficacy and safety study of benralizumab for patients with severe nasal polyposis (OSTRO). Accessed May 29 2019.https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03401229?term=NCT03401229&rank=1"},{"key":"e_1_2_16_58_1","doi-asserted-by":"publisher","DOI":"10.1002\/lary.26391"},{"issue":"7","key":"e_1_2_16_59_1","article-title":"Analysis of comorbidities and objective parameters in refractory chronic rhinosinusitis","volume":"123","author":"Batra PS","year":"2013","journal-title":"Laryngoscope"},{"key":"e_1_2_16_60_1","doi-asserted-by":"publisher","DOI":"10.1002\/lary.24027"},{"key":"e_1_2_16_61_1","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v3.i6.499"},{"key":"e_1_2_16_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.alit.2015.01.004"},{"key":"e_1_2_16_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2017.03.050"},{"key":"e_1_2_16_64_1","doi-asserted-by":"publisher","DOI":"10.1111\/all.13048"},{"key":"e_1_2_16_65_1","doi-asserted-by":"publisher","DOI":"10.1177\/0194599811435638"},{"key":"e_1_2_16_66_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005537-200310000-00008"},{"key":"e_1_2_16_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(15)00367-7"},{"key":"e_1_2_16_68_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri3786"},{"key":"e_1_2_16_69_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00938\u20102018"},{"key":"e_1_2_16_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2017.12.001"},{"key":"e_1_2_16_71_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-018-0823-y"},{"key":"e_1_2_16_72_1","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2001.117880"},{"key":"e_1_2_16_73_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.01.00092101"},{"key":"e_1_2_16_74_1","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2003.54"},{"key":"e_1_2_16_75_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.02.00016502"},{"key":"e_1_2_16_76_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201103-0396OC"},{"key":"e_1_2_16_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2016.03.032"},{"key":"e_1_2_16_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(15)00042-9"},{"key":"e_1_2_16_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2016.03.018"},{"key":"e_1_2_16_80_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2017.08.024"},{"key":"e_1_2_16_81_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60988-X"},{"key":"e_1_2_16_82_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1403290"},{"key":"e_1_2_16_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(17)30125-X"},{"key":"e_1_2_16_84_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1403291"},{"key":"e_1_2_16_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2016.07.010"},{"key":"e_1_2_16_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(14)70201-2"},{"key":"e_1_2_16_87_1","doi-asserted-by":"publisher","DOI":"10.2147\/JAA.S157762"},{"key":"e_1_2_16_88_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(17)30190-X"},{"key":"e_1_2_16_89_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1703501"},{"key":"e_1_2_16_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(18)30406-5"},{"key":"e_1_2_16_91_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)31324-1"},{"key":"e_1_2_16_92_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)31322-8"},{"key":"e_1_2_16_93_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1304048"},{"key":"e_1_2_16_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)30307-5"},{"key":"e_1_2_16_95_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1804092"},{"key":"e_1_2_16_96_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1804093"},{"key":"e_1_2_16_97_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-012-2077-6"},{"key":"e_1_2_16_98_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2019.07.012"},{"key":"e_1_2_16_99_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2010.11.037"},{"key":"e_1_2_16_100_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1081-1206(10)60465-6"},{"key":"e_1_2_16_101_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-3003.2000.016003432.x"},{"key":"e_1_2_16_102_1","doi-asserted-by":"publisher","DOI":"10.1111\/all.13599"},{"key":"e_1_2_16_103_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1712125"},{"key":"e_1_2_16_104_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2015.09.034"},{"issue":"3","key":"e_1_2_16_105_1","first-page":"1045","article-title":"A retrospective analysis of mepolizumab in subjects with aspirin\u2010exacerbated respiratory disease","volume":"6","author":"Tuttle KL","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"e_1_2_16_106_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2019.03.044"},{"key":"e_1_2_16_107_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.37715"},{"key":"e_1_2_16_108_1","first-page":"48","article-title":"Diagnosis and classification of eosinophilic granulomatosis with polyangiitis (formerly named Churg\u2010Strauss syndrome)","author":"Mouthon L","year":"2014","journal-title":"J Autoimmunity"},{"key":"e_1_2_16_109_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-143-9-200511010-00006"},{"key":"e_1_2_16_110_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2015.04.022"},{"key":"e_1_2_16_111_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00097-2016"},{"key":"e_1_2_16_112_1","unstructured":"GSK.Mepolizumab prescribing information. Accessed May 14 2019.https:\/\/www.gsksource.com\/pharma\/content\/dam\/GlaxoSmithKline\/US\/en\/Prescribing_Information\/Nucala\/pdf\/NUCALA\u2010PI\u2010PIL.PDF"},{"key":"e_1_2_16_113_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1702079"},{"key":"e_1_2_16_114_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.101279"},{"key":"e_1_2_16_115_1","doi-asserted-by":"publisher","DOI":"10.1111\/all.13397"},{"key":"e_1_2_16_116_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2014.02.036"},{"key":"e_1_2_16_117_1","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2014.306"},{"key":"e_1_2_16_118_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1215372"},{"key":"e_1_2_16_119_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2013.05.013"},{"key":"e_1_2_16_120_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.10.010"},{"key":"e_1_2_16_121_1","unstructured":"Food and Drug Administration.Dupilumab package insert. Accessed May 29 2019.https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2017\/761055lbl.pdf"},{"key":"e_1_2_16_122_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1700366"},{"key":"e_1_2_16_123_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31191-1"},{"key":"e_1_2_16_124_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2007.09.032"},{"key":"e_1_2_16_125_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.6072"},{"key":"e_1_2_16_126_1","unstructured":"Institute for Clinical and Economic Review.Biologic Therapies for Treatment of Asthma Associated With Type 2 Inflamation: Effectiveness Value and Value\u2010Based Price Benchmarks: Final Evidence Report. Published 2018. Accessed May 29 2019.https:\/\/icer\u2010review.org\/material\/asthma\u2010final\u2010evidence\u2010report\/"},{"key":"e_1_2_16_127_1","doi-asserted-by":"publisher","DOI":"10.1002\/lary.28648"}],"container-title":["Otolaryngology\u2013Head and Neck Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1177\/0194599820965233","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1177\/0194599820965233","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/aao-hnsfjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1177\/0194599820965233","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T11:58:42Z","timestamp":1760961522000},"score":1,"resource":{"primary":{"URL":"https:\/\/aao-hnsfjournals.onlinelibrary.wiley.com\/doi\/10.1177\/0194599820965233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,3]]},"references-count":126,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["10.1177\/0194599820965233"],"URL":"https:\/\/doi.org\/10.1177\/0194599820965233","archive":["Portico"],"relation":{},"ISSN":["0194-5998","1097-6817"],"issn-type":[{"value":"0194-5998","type":"print"},{"value":"1097-6817","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,3]]},"assertion":[{"value":"2020-07-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-09-15","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-11-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}